MedPath

The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps

Phase 4
Conditions
Combizym
Colon Polyps
Bifidobacteri
Interventions
Drug: Bifidobacteri
Drug: Combizym + Bifidobacteri
Registration Number
NCT02097394
Lead Sponsor
RenJi Hospital
Brief Summary

The study hypothesis is whether digestion enzyme(Combizym) and intestinal flora drugs(Bifidobacteria) can decease recurrence rate of colon polyps

Detailed Description

Colon polyps has high recurrence rate in the digestion diseases. However, the reasons are not clear. The possible reasons for the recurrence of colon polyps include intestinal inflammation (e.g., Ulcerative colitis), intestinal flora imbalance (the benefit intestinal bacteria reduced, which lead to diarrhea or constipation), long-term indigestion. The investigators propose to examine whether digestion enzyme (Combizym) and intestinal flora drugs(Bifidobacteria) can decease recurrence rate of colon polyps

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria

-Patients who have cutted colon polyps in one month, and the diagnosis were proved by pathological analysis

Exclusion Criteria
  • have organic or other functional disease
  • pregnant or breast-feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bifidobacteri-treated groupBifidobacteriThe patients who received polypectomy of colon polyps take Bifidobacteri regularly
Combizym + Bifidobacteri-treated groupCombizym + BifidobacteriThe patients who received polypectomy of colon polyps take drugs (Combizym + Bifidobacteri) regularly
Combizym-treated groupCombizymThe patients who received polypectomy of colon polyps take the digestion enzyme (Combizym) regularly.
Primary Outcome Measures
NameTimeMethod
recurrence of colon polypsone year

The whole patients need be examined by colonoscopy one year later. The recurrence rate of colon polyps will be acquired in different arms

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Renji Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath